Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy

Davide Stolfo1, Nicole Ceschia1, Massimo Zecchin1

  • 1Department of Cardiology, Azienda Sanitaria Universitaria Integrata, Trieste, Italy.

Insights

Risk factors for sudden cardiac death in idiopathic dilated cardiomyopathy change over time. Different predictors are crucial for risk stratification at baseline, short-term, and long-term assessments to improve patient outcomes.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Research

Background:

  • Idiopathic dilated cardiomyopathy (IDC) poses significant risks for life-threatening arrhythmias.
  • Effective risk stratification for arrhythmic events in IDC patients is challenging due to evolving disease progression.

Purpose of the Study:

  • To dynamically assess arrhythmic risk factors in IDC patients over time.
  • To identify changing predictors of adverse arrhythmic events at different time points.

Main Methods:

  • Retrospective analysis of 710 IDC patients without prior ventricular arrhythmias.
  • Landmark analysis at baseline, 12 months, and 72 months to evaluate risk predictors.
  • Development of multivariate models combining significant predictors at each time point.

Main Results:

  • Baseline predictors included QRS duration, disease duration, and mitral regurgitation.
  • Short-term (12 months) predictors comprised disease duration, syncope, NYHA class III/IV, and indexed left ventricular end-diastolic volume.
  • Long-term (72 months) predictors were indexed left ventricular end-diastolic volume, left ventricular ejection fraction, and left atrial area.
  • All models demonstrated good predictive accuracy (AUC 0.76-0.82).

Conclusions:

  • Arrhythmic risk stratification in IDC requires dynamic assessment, considering different predictors at various time points.
  • Impaired left ventricular ejection fraction is a significant long-term predictor of major arrhythmias in IDC.
  • Understanding temporal changes in risk factors is crucial for optimizing management and implantable cardioverter-defibrillator therapy.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
589
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
526
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
587
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
470
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
619
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
365